Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2020-02-13 10:14 am Sale | 13D | DMK PHARMACEUTICALS CORP COM P DMKPQ | 683 Capital Management LLC | 1,750,000 2.8% | -2,362,885 (-57.45%) | View |
2020-02-13 10:11 am Sale | 13G | GALMED PHARMACEUTICALS LTD. SH GLMD | 683 Capital Management LLC | 800,000 3.8% | -550,000 (-40.74%) | View |
2020-02-13 10:09 am Purchase | 13G | EIGER BIOPHARMACEUTICALS INC C EIGR | 683 Capital Management LLC | 1,850,000 7.6% | 239,471 (+14.87%) | View |
2020-02-13 10:07 am Purchase | 13G | ALDEYRA THERAPEUTICS, INC ALDX | 683 Capital Management LLC | 1,727,700 6.2% | 334,000 (+23.96%) | View |
2020-02-13 10:06 am Sale | 13G | NII HOLDINGS INC NIHD | 683 Capital Management LLC | 0 0% | -13,163,432 (Position Closed) | View |
2020-02-13 10:04 am Purchase | 13G | LARIMAR THERAPEUTICS INC LRMR | 683 Capital Management LLC | 2,701,566 7.2% | 370,153 (+15.88%) | View |
2020-02-13 10:03 am Sale | 13G | trivago N.V. TRVG | 683 Capital Management LLC | 2,156,700 4.3% | -3,443,300 (-61.49%) | View |
2020-02-13 10:02 am Sale | 13G | Tracon Pharmaceuticals Inc. TCON | 683 Capital Management LLC | 258,893 8.3% | -2,722,357 (-91.32%) | View |
2020-02-13 10:00 am Sale | 13G | Syndax Pharmaceuticals Inc SNDX | 683 Capital Management LLC | 1,153,373 4.2% | -189,466 (-14.11%) | View |
2020-02-13 09:58 am Sale | 13G | SOLENO THERAPEUTICS INC SLNO | 683 Capital Management LLC | 1,024,330 2.3% | -422,225 (-29.19%) | View |
2020-02-13 09:57 am Sale | 13G | SELLAS LIFE SCIENCES GROUP INC SLS | 683 Capital Management LLC | 38,000 1% | -1,237,000 (-97.02%) | View |
2020-02-13 09:55 am Sale | 13G | REDHILL BIOPHARMA LTD RDHL | 683 Capital Management LLC | 1,034,650 3.6% | -2,659,190 (-71.99%) | View |
2020-02-13 09:52 am Sale | 13G | Eledon Pharmaceuticals Inc. ELDN | 683 Capital Management LLC | 946,204 7% | -246,613 (-20.67%) | View |
2020-02-13 09:50 am Purchase | 13G | INSPIRED ENTMT INC INSE | 683 Capital Management LLC | 1,995,869 8.3% | 1,250 (+0.06%) | View |
2020-02-13 09:47 am Sale | 13G | Sequential Brands Group Inc. SQBG | 683 Capital Management LLC | 500,000 1% | -2,856,200 (-85.10%) | View |
2019-09-20 3:20 pm Sale | 13D | TRAWS PHARMA, INC. TRAW | 683 Capital Management LLC | 593,334 9.7% | -15,909,835 (-96.40%) | View |
2019-09-16 4:43 pm Purchase | 13G | LARIMAR THERAPEUTICS INC LRMR | 683 Capital Management LLC | 2,331,413 6.2% | 2,331,413 (New Position) | View |
2019-08-12 5:29 pm Purchase | 13G | DMK PHARMACEUTICALS CORP COM P DMKPQ | 683 Capital Management LLC | 4,112,885 6.7% | 4,112,885 (New Position) | View |
2019-07-26 2:48 pm Purchase | 13G | Eledon Pharmaceuticals Inc. ELDN | 683 Capital Management LLC | 1,192,817 8.8% | 1,192,817 (New Position) | View |
2019-06-28 5:00 pm Unchanged | 13D | MAIDEN HOLDINGS LTD MHLD | 683 Capital Management LLC | 7,876,964 9.49% | 0 (Unchanged) | View |